DECIDE: Dyads and Families
Decision-Making Experiences for Culturally Inclusive Dementia Engagement: Dyads and Families (DECIDE: Dyads and Families)
2 other identifiers
interventional
40
1 country
4
Brief Summary
The purpose of this study is to design and test a decision-making program that is tailored to support adult daughters making healthcare decisions for their parents who are living with memory loss to improve the quality of life of African American families. There are two phases of this research study. The first phase will collect information by surveys and/or interviews. The surveys and interviews will ask questions about demographics (e.g., age, race/ethnicity), culture, health, family dynamics, caregiving, and healthcare experiences. The surveys will be completed by all eligible adult daughters and parents with memory loss in pairs. The interviews will be completed by a smaller number of pairs and by all former adult daughter caregivers. The general scope of topics is caregiving experiences, cultural identity, healthcare decisions for persons living with Alzheimer's disease, and related dementias, health, and well-being. The research team will identify and examine key factors that will lead to designing and testing the feasibility of a culturally tailored prototype intervention for African American dementia dyads/families of persons living with mild to moderate Alzheimer's disease and related dementias.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2022
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 4, 2021
CompletedFirst Posted
Study publicly available on registry
December 1, 2021
CompletedStudy Start
First participant enrolled
July 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
July 3, 2025
June 1, 2025
4.4 years
November 4, 2021
June 30, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Participant retention
Acceptability of the intervention will be assessed with participant retention. Retention of 80% of participants from baseline to 3-month follow-up is considered successful. Attendance of dyads during program sessions during the intervention phase. The goal is to maintain ≥ 70% attendance at program sessions
eight weeks
Usability of Intervention
Usability of the intervention will be assessed with a qualitative interview with the African American parent-adult daughter dyads after completing the intervention. There is not a summary score for the open-ended questions asked during the interview.
Upon completion of the intervention (estimated to be 8 weeks)
Percentage of recruitment goal achieved
The feasibility of the intervention will be assessed as successful recruitment of study participants. This study aims to recruit 20 African American parent-adult daughter dementia dyads in ≤ 6 months. The actual recruited number of dyads will be reported as the percentage of dyads recruited within 6 months divided by 20 (actual/goal).
Up to 6 months after the start of recruitment
Change in Quality of Life-Alzheimer's Disease (QoL-AD) Scale Score
The preliminary efficacy of the intervention will be assessed with the Quality of Life-Alzheimer's Disease (QoL-AD) scale. The QoL-AD has 13 items which are scored as poor = 1, fair = 2, good = 3, excellent = 4. The total score ranges from 13 to 52 and higher scores indicate a greater quality of life.
0-month, 1 month, 3 months
Change in Decision Self-Efficacy Scale Score
The preliminary efficacy of the intervention will be assessed with the Decision Self-Efficacy Scale. The Decision Self-Efficacy Scale has 11 items which are scored as not at all confident = 0 to very confident = 5. The total score ranges from 0 to 100 and higher scores indicate greater self-efficacy.
0-month, 1 month, 3 months
Study Arms (1)
Prototype Intervention
EXPERIMENTALThe prototype intervention will be likely family-based and focused on issues of communication, problem-solving, health system literacy, and family systems, all considered in the context of the African-American (AA) adult daughter role and cultural identity.
Interventions
The prototype intervention will be likely family-based and focused on issues of communication, problem-solving, health system literacy, and family systems, all considered in the context of the African-American (AA) adult daughter role and cultural identity.
Eligibility Criteria
You may qualify if:
- self-identifies as African American
- age 50 years or older
- community-dwelling
- experiencing signs and symptoms of mild to moderate dementia through family caregiver report on the Dementia Severity Rating Scale and meeting the National Institute on Aging and the Alzheimer's Association clinical criteria for probable (Alzheimer's Disease (AD)
- able to read, speak, and understand English
- willing to participate.
You may not qualify if:
- any confounding significant neurologic diseases (e.g., Parkinson's) or a major psychiatric disorder (e.g., schizophrenia).
- Caregiver:
- self-identifies as African American
- years of age or older
- daughter/daughter-in-law (including non-blood individuals)
- aids in activities of daily living and/or instrumental activities of daily living for the PLWD
- makes/takes part in formal care decisions
- able to read, speak, and understand English
- cognitively intact
- access to an internet connection
- access to a phone or computer that accepts emails.
- Key informants:
- Meet the criteria for PLWD and caregiver
- has experience navigating at least 2 of the following for their parent living with dementia: assisting the PLWD with getting a formal diagnosis of Alzheimer's disease and related dementias, finding/changing a healthcare provider, medication management, receiving treatment or having a procedure, conversations about hospice, palliative care, and/or end-of-life care.
- Past caregiver:
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (4)
Zeta Phi Beta Sorority, Inc.
Washington D.C., District of Columbia, 20009, United States
Emory Healthcare Integrated Memory Care Clinic
Atlanta, Georgia, 30329, United States
Emory University Goizueta Alzheimer's Disease Research Center Minority Engagement Core
Atlanta, Georgia, 30329, United States
Metro-Atlanta
Atlanta, Georgia, 30340, United States
Related Publications (1)
Bonds Johnson K, Lyons KS, Epps F, Daniel G, Monin JK, Powell W, Hepburn K. Development and evaluation of a healthcare decision-making intervention for African American parent-adult daughter dementia dyads: a mixed-methods study protocol. BMJ Open. 2025 Mar 13;15(3):e099976. doi: 10.1136/bmjopen-2025-099976.
PMID: 40081986DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kalisha Bonds Johnson, PhD RN PMHNP
Emory University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 4, 2021
First Posted
December 1, 2021
Study Start
July 15, 2022
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 3, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- six months after publication.
- Access Criteria
- Researchers will share the data with qualified researchers who complete a formal data sharing agreement for research purposes only.
Researchers will share demographic data, study measures, and outcome variables